TransPharma Medical Ltd. Announces Successful Results of a 4 Week Phase 1 Clinical Trial of Its New Self-applied ViaDerm System for the Treatment of Osteoporosis
LOD, Israel--(BUSINESS WIRE)--TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today successful results of a 4 week Phase 1 trial of its new self-applied ViaDerm-hPTH(1-34) for the treatment of osteoporosis.